Human Placenta Mesenchymal Stem Cell-Derived Exosome Shuttling MicroRNA-130b-3p from Gestational Diabetes Mellitus Patients Targets ICAM-1 and Perturbs Human Umbilical Vein Endothelial Cell Angiogenesis

Human placenta mesenchymal stem cells from gestational diabetes mellitus patients derived exosomes shuttling miR-130b-3p repressed proliferation, migration, and angiogenesis of human umbilical vein endothelial cells by regulating ICAM-1 expression.